Jennifer Doan

Array ( [id] => 5253989 [patent_doc_number] => 20070135445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Bicyclic Indolyl Derivatives and Methods for Their Use as Serotonergic Agents' [patent_app_type] => utility [patent_app_number] => 11/623225 [patent_app_country] => US [patent_app_date] => 2007-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10608 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135445.pdf [firstpage_image] =>[orig_patent_app_number] => 11623225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120685 [patent_doc_number] => 20070142400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Enantjomers of 1-[(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine' [patent_app_type] => utility [patent_app_number] => 11/652092 [patent_app_country] => US [patent_app_date] => 2007-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11009 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142400.pdf [firstpage_image] =>[orig_patent_app_number] => 11652092 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4507939 [patent_doc_number] => 07915260 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-29 [patent_title] => 'Urotensin II receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/651848 [patent_app_country] => US [patent_app_date] => 2007-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 96237 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/915/07915260.pdf [firstpage_image] =>[orig_patent_app_number] => 11651848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253990 [patent_doc_number] => 20070135446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Benzoylguanidlne salt and hydrates thereof' [patent_app_type] => utility [patent_app_number] => 11/649632 [patent_app_country] => US [patent_app_date] => 2007-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2147 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135446.pdf [firstpage_image] =>[orig_patent_app_number] => 11649632 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7688622 [patent_doc_number] => 20070106076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-10 [patent_title] => 'Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino [1,2-a] indoles' [patent_app_type] => utility [patent_app_number] => 11/649132 [patent_app_country] => US [patent_app_date] => 2007-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37808 [patent_no_of_claims] => 127 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20070106076.pdf [firstpage_image] =>[orig_patent_app_number] => 11649132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5474341 [patent_doc_number] => 20090247507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Enzyme Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/158339 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88014 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247507.pdf [firstpage_image] =>[orig_patent_app_number] => 12158339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 285542 [patent_doc_number] => 07550469 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-23 [patent_title] => 'Heterocyclic amide derivatives and their use as dopamine D3 receptor ligands' [patent_app_type] => utility [patent_app_number] => 11/643594 [patent_app_country] => US [patent_app_date] => 2006-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42155 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/550/07550469.pdf [firstpage_image] =>[orig_patent_app_number] => 11643594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8201079 [patent_doc_number] => 08188089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-29 [patent_title] => 'Tylophorine analogs as antitumor agents' [patent_app_type] => utility [patent_app_number] => 12/096950 [patent_app_country] => US [patent_app_date] => 2006-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16833 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/188/08188089.pdf [firstpage_image] =>[orig_patent_app_number] => 12096950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853202 [patent_doc_number] => 20080318945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Novel Compounds' [patent_app_type] => utility [patent_app_number] => 12/097114 [patent_app_country] => US [patent_app_date] => 2006-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21020 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318945.pdf [firstpage_image] =>[orig_patent_app_number] => 12097114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5311056 [patent_doc_number] => 20090018337 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'PROCESS FOR THE PREPARATION OF A PHARMACEUTICAL INTERMEDIATE' [patent_app_type] => utility [patent_app_number] => 12/096630 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2774 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018337.pdf [firstpage_image] =>[orig_patent_app_number] => 12096630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7691420 [patent_doc_number] => 20070232613 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Inhibitors of macrophage migration inhibitory factor and methods for identifying the same' [patent_app_type] => utility [patent_app_number] => 11/635319 [patent_app_country] => US [patent_app_date] => 2006-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 41941 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232613.pdf [firstpage_image] =>[orig_patent_app_number] => 11635319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120643 [patent_doc_number] => 20070142358 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Pyrrolo [2,3-B] pyridine derivatives' [patent_app_type] => utility [patent_app_number] => 11/634563 [patent_app_country] => US [patent_app_date] => 2006-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11753 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142358.pdf [firstpage_image] =>[orig_patent_app_number] => 11634563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120644 [patent_doc_number] => 20070142359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'Pyrrolo [2,3-c] pyridine derivatives' [patent_app_type] => utility [patent_app_number] => 11/634617 [patent_app_country] => US [patent_app_date] => 2006-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13432 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142359.pdf [firstpage_image] =>[orig_patent_app_number] => 11634617 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949957 [patent_doc_number] => 20080306083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Biaryl Compounds Useful as Agonists of the Gpr38 Receptor' [patent_app_type] => utility [patent_app_number] => 12/096104 [patent_app_country] => US [patent_app_date] => 2006-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17213 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306083.pdf [firstpage_image] =>[orig_patent_app_number] => 12096104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5080308 [patent_doc_number] => 20070123532 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'PIPERAZINE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/562149 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63631 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20070123532.pdf [firstpage_image] =>[orig_patent_app_number] => 11562149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5131635 [patent_doc_number] => 20070208032 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'Chemical compounds' [patent_app_type] => utility [patent_app_number] => 11/601854 [patent_app_country] => US [patent_app_date] => 2006-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7567 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20070208032.pdf [firstpage_image] =>[orig_patent_app_number] => 11601854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6329553 [patent_doc_number] => 20100197910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'PROCESS FOR PREPARATION OF PRULIFLOXACIN USING NOVEL INTERMEDIATES' [patent_app_type] => utility [patent_app_number] => 11/916649 [patent_app_country] => US [patent_app_date] => 2006-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2376 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197910.pdf [firstpage_image] =>[orig_patent_app_number] => 11916649 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368824 [patent_doc_number] => 20090306383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Method for Producing 2-(4-Methyl-2-Phenylpiperazin-1-Yl)Pyridine-3-Methanol' [patent_app_type] => utility [patent_app_number] => 12/084652 [patent_app_country] => US [patent_app_date] => 2006-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2030 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306383.pdf [firstpage_image] =>[orig_patent_app_number] => 12084652 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 221165 [patent_doc_number] => 07608711 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-27 [patent_title] => 'Process for the preparation of ziprasidone' [patent_app_type] => utility [patent_app_number] => 11/595861 [patent_app_country] => US [patent_app_date] => 2006-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2091 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/608/07608711.pdf [firstpage_image] =>[orig_patent_app_number] => 11595861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5189148 [patent_doc_number] => 20070167457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'N-AROYL PIPERAZINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 11/557998 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10201 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167457.pdf [firstpage_image] =>[orig_patent_app_number] => 11557998 [rel_patent_id] =>[rel_patent_doc_number] =>)